Clinical trial
The Effect of Capsaicin-Phenylephrine-Caffeine Formulation on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
NCT04972123 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Capsaicin-Phenylephrine-Caffeine Formulation on Aborting Tilt Induced Syncope in Patients With a History of Vasovagal Syncope or Near Syncope
- Lead sponsor
- University of Wisconsin, Madison
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 20, 2021
- Completion date
- August 31, 2023
- Enrollment
- 143 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.